Catalyst Wire Dossier Catalyst Wire Dossier

Oxybuprocaine 0.4% Eye Drops

Oxybuprocaine · Sintetica SA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxybuprocaine 0.4% Eye Drops, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Chloroprocaine 3% Gel and Oxybuprocaine 0.4% Eye Drops Anesthesia in Pediatric Population [Phase 3]

See pricing